Summary

The global Universal CAR-T Cell Therapy market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Off-the-shelf CAR-T cells are CAR-T cells prepared using allogeneic T cells, also known as "off-the-shelf" and universal. Usually, T cells are collected from healthy donors or T cells derived from stem cells are used directly. After HLA matching, a successfully designed CAR (such as CD19 CAR) is loaded onto the surface of the T cells.
In 2025, the North America Universal CAR-T Cell Therapy market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Universal CAR-T Cell Therapy include Cellectis, Allogene, Caribou, Poseida Therapeutics, Bangyao Biotechnology, Usano, Keji Pharmaceutical, Beiheng Biotechnology, Grace Biotechnology, Celyad, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Universal CAR-T Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Cellectis
Allogene
Caribou
Poseida Therapeutics
Bangyao Biotechnology
Usano
Keji Pharmaceutical
Beiheng Biotechnology
Grace Biotechnology
Celyad
CRISPR Therapeutics
Precision BioSciences
Segment by Type
First Generation CARs
Second Generation CARs
Third Generation CARs
Segment by Application
Hematoma
Solid Tumor
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Universal CAR-T Cell Therapy market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Universal CAR-T Cell Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 First Generation CARs
1.2.3 Second Generation CARs
1.2.4 Third Generation CARs
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hematoma
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Universal CAR-T Cell Therapy Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Universal CAR-T Cell Therapy Market Share by Revenue, by Region (2021-2026)
2.4 Global Universal CAR-T Cell Therapy Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Universal CAR-T Cell Therapy Market Size and Prospective (2021-2032)
2.5.2 Europe Universal CAR-T Cell Therapy Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Universal CAR-T Cell Therapy Market Size and Prospective (2021-2032)
2.5.4 Latin America Universal CAR-T Cell Therapy Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Universal CAR-T Cell Therapy Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Universal CAR-T Cell Therapy Historical Market Size by Type (2021-2026)
3.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Universal CAR-T Cell Therapy

4 Breakdown Data by Application
4.1 Global Universal CAR-T Cell Therapy Historical Market Size by Application (2021-2026)
4.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Universal CAR-T Cell Therapy Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Universal CAR-T Cell Therapy Players by Revenue (2021-2026)
5.1.2 Global Universal CAR-T Cell Therapy Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Universal CAR-T Cell Therapy Revenue
5.4 Global Universal CAR-T Cell Therapy Market Concentration Analysis
5.4.1 Global Universal CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Universal CAR-T Cell Therapy Revenue in 2025
5.5 Global Key Players of Universal CAR-T Cell Therapy Head Offices and Areas Served
5.6 Global Key Players of Universal CAR-T Cell Therapy, Product and Application
5.7 Global Key Players of Universal CAR-T Cell Therapy, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Universal CAR-T Cell Therapy Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Universal CAR-T Cell Therapy Market Size by Type (2021-2026)
6.1.2.2 North America Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Universal CAR-T Cell Therapy Market Size by Application (2021-2026)
6.1.3.2 North America Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
6.1.4 North America Universal CAR-T Cell Therapy Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Universal CAR-T Cell Therapy Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Universal CAR-T Cell Therapy Market Size by Type (2021-2026)
6.2.2.2 Europe Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Universal CAR-T Cell Therapy Market Size by Application (2021-2026)
6.2.3.2 Europe Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
6.2.4 Europe Universal CAR-T Cell Therapy Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Universal CAR-T Cell Therapy Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Universal CAR-T Cell Therapy Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Universal CAR-T Cell Therapy Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Universal CAR-T Cell Therapy Market Size by Type (2021-2026)
6.4.2.2 Latin America Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Universal CAR-T Cell Therapy Market Size by Application (2021-2026)
6.4.3.2 Latin America Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
6.4.4 Latin America Universal CAR-T Cell Therapy Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Universal CAR-T Cell Therapy Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Universal CAR-T Cell Therapy Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Cellectis
7.1.1 Cellectis Company Details
7.1.2 Cellectis Business Overview
7.1.3 Cellectis Universal CAR-T Cell Therapy Introduction
7.1.4 Cellectis Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.1.5 Cellectis Recent Development
7.2 Allogene
7.2.1 Allogene Company Details
7.2.2 Allogene Business Overview
7.2.3 Allogene Universal CAR-T Cell Therapy Introduction
7.2.4 Allogene Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.2.5 Allogene Recent Development
7.3 Caribou
7.3.1 Caribou Company Details
7.3.2 Caribou Business Overview
7.3.3 Caribou Universal CAR-T Cell Therapy Introduction
7.3.4 Caribou Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.3.5 Caribou Recent Development
7.4 Poseida Therapeutics
7.4.1 Poseida Therapeutics Company Details
7.4.2 Poseida Therapeutics Business Overview
7.4.3 Poseida Therapeutics Universal CAR-T Cell Therapy Introduction
7.4.4 Poseida Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.4.5 Poseida Therapeutics Recent Development
7.5 Bangyao Biotechnology
7.5.1 Bangyao Biotechnology Company Details
7.5.2 Bangyao Biotechnology Business Overview
7.5.3 Bangyao Biotechnology Universal CAR-T Cell Therapy Introduction
7.5.4 Bangyao Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.5.5 Bangyao Biotechnology Recent Development
7.6 Usano
7.6.1 Usano Company Details
7.6.2 Usano Business Overview
7.6.3 Usano Universal CAR-T Cell Therapy Introduction
7.6.4 Usano Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.6.5 Usano Recent Development
7.7 Keji Pharmaceutical
7.7.1 Keji Pharmaceutical Company Details
7.7.2 Keji Pharmaceutical Business Overview
7.7.3 Keji Pharmaceutical Universal CAR-T Cell Therapy Introduction
7.7.4 Keji Pharmaceutical Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.7.5 Keji Pharmaceutical Recent Development
7.8 Beiheng Biotechnology
7.8.1 Beiheng Biotechnology Company Details
7.8.2 Beiheng Biotechnology Business Overview
7.8.3 Beiheng Biotechnology Universal CAR-T Cell Therapy Introduction
7.8.4 Beiheng Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.8.5 Beiheng Biotechnology Recent Development
7.9 Grace Biotechnology
7.9.1 Grace Biotechnology Company Details
7.9.2 Grace Biotechnology Business Overview
7.9.3 Grace Biotechnology Universal CAR-T Cell Therapy Introduction
7.9.4 Grace Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.9.5 Grace Biotechnology Recent Development
7.10 Celyad
7.10.1 Celyad Company Details
7.10.2 Celyad Business Overview
7.10.3 Celyad Universal CAR-T Cell Therapy Introduction
7.10.4 Celyad Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.10.5 Celyad Recent Development
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Company Details
7.11.2 CRISPR Therapeutics Business Overview
7.11.3 CRISPR Therapeutics Universal CAR-T Cell Therapy Introduction
7.11.4 CRISPR Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.11.5 CRISPR Therapeutics Recent Development
7.12 Precision BioSciences
7.12.1 Precision BioSciences Company Details
7.12.2 Precision BioSciences Business Overview
7.12.3 Precision BioSciences Universal CAR-T Cell Therapy Introduction
7.12.4 Precision BioSciences Revenue in Universal CAR-T Cell Therapy Business (2021-2026)
7.12.5 Precision BioSciences Recent Development

8 Universal CAR-T Cell Therapy Market Dynamics
8.1 Universal CAR-T Cell Therapy Industry Trends
8.2 Universal CAR-T Cell Therapy Market Drivers
8.3 Universal CAR-T Cell Therapy Market Challenges
8.4 Universal CAR-T Cell Therapy Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Universal CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Universal CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Universal CAR-T Cell Therapy Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Universal CAR-T Cell Therapy Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Universal CAR-T Cell Therapy Revenue Share by Region (2021-2026)
Table 6. Global Universal CAR-T Cell Therapy Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Universal CAR-T Cell Therapy Revenue Share Forecast by Region (2027-2032)
Table 8. Global Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Universal CAR-T Cell Therapy Market Share by Revenue, by Type (2021-2026)
Table 10. Global Universal CAR-T Cell Therapy Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Universal CAR-T Cell Therapy Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Universal CAR-T Cell Therapy Market Share by Revenue, by Application (2021-2026)
Table 15. Global Universal CAR-T Cell Therapy Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Universal CAR-T Cell Therapy Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Universal CAR-T Cell Therapy Applications
Table 18. Global Universal CAR-T Cell Therapy Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Universal CAR-T Cell Therapy Market Share by Players (2021-2026)
Table 20. Global Top Universal CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Universal CAR-T Cell Therapy as of 2025)
Table 21. Ranking of Global Top Universal CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Universal CAR-T Cell Therapy Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Universal CAR-T Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Universal CAR-T Cell Therapy, Product and Application
Table 25. Global Key Players of Universal CAR-T Cell Therapy, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Universal CAR-T Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Universal CAR-T Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 29. North America Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Universal CAR-T Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Universal CAR-T Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Universal CAR-T Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Universal CAR-T Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Universal CAR-T Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Universal CAR-T Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Universal CAR-T Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Universal CAR-T Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Universal CAR-T Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Universal CAR-T Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 47. Cellectis Company Details
Table 48. Cellectis Business Overview
Table 49. Cellectis Universal CAR-T Cell Therapy Product
Table 50. Cellectis Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 51. Cellectis Recent Development
Table 52. Allogene Company Details
Table 53. Allogene Business Overview
Table 54. Allogene Universal CAR-T Cell Therapy Product
Table 55. Allogene Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 56. Allogene Recent Development
Table 57. Caribou Company Details
Table 58. Caribou Business Overview
Table 59. Caribou Universal CAR-T Cell Therapy Product
Table 60. Caribou Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 61. Caribou Recent Development
Table 62. Poseida Therapeutics Company Details
Table 63. Poseida Therapeutics Business Overview
Table 64. Poseida Therapeutics Universal CAR-T Cell Therapy Product
Table 65. Poseida Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 66. Poseida Therapeutics Recent Development
Table 67. Bangyao Biotechnology Company Details
Table 68. Bangyao Biotechnology Business Overview
Table 69. Bangyao Biotechnology Universal CAR-T Cell Therapy Product
Table 70. Bangyao Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 71. Bangyao Biotechnology Recent Development
Table 72. Usano Company Details
Table 73. Usano Business Overview
Table 74. Usano Universal CAR-T Cell Therapy Product
Table 75. Usano Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 76. Usano Recent Development
Table 77. Keji Pharmaceutical Company Details
Table 78. Keji Pharmaceutical Business Overview
Table 79. Keji Pharmaceutical Universal CAR-T Cell Therapy Product
Table 80. Keji Pharmaceutical Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 81. Keji Pharmaceutical Recent Development
Table 82. Beiheng Biotechnology Company Details
Table 83. Beiheng Biotechnology Business Overview
Table 84. Beiheng Biotechnology Universal CAR-T Cell Therapy Product
Table 85. Beiheng Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 86. Beiheng Biotechnology Recent Development
Table 87. Grace Biotechnology Company Details
Table 88. Grace Biotechnology Business Overview
Table 89. Grace Biotechnology Universal CAR-T Cell Therapy Product
Table 90. Grace Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 91. Grace Biotechnology Recent Development
Table 92. Celyad Company Details
Table 93. Celyad Business Overview
Table 94. Celyad Universal CAR-T Cell Therapy Product
Table 95. Celyad Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 96. Celyad Recent Development
Table 97. CRISPR Therapeutics Company Details
Table 98. CRISPR Therapeutics Business Overview
Table 99. CRISPR Therapeutics Universal CAR-T Cell Therapy Product
Table 100. CRISPR Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 101. CRISPR Therapeutics Recent Development
Table 102. Precision BioSciences Company Details
Table 103. Precision BioSciences Business Overview
Table 104. Precision BioSciences Universal CAR-T Cell Therapy Product
Table 105. Precision BioSciences Revenue in Universal CAR-T Cell Therapy Business (2021-2026) & (US$ Million)
Table 106. Precision BioSciences Recent Development
Table 107. Universal CAR-T Cell Therapy Market Trends
Table 108. Universal CAR-T Cell Therapy Market Drivers
Table 109. Universal CAR-T Cell Therapy Market Challenges
Table 110. Universal CAR-T Cell Therapy Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List of Figures
Figure 1. Universal CAR-T Cell Therapy Product Picture
Figure 2. Global Universal CAR-T Cell Therapy Market Share by Type: 2025 vs 2032
Figure 3. First Generation CARs Features
Figure 4. Second Generation CARs Features
Figure 5. Third Generation CARs Features
Figure 6. Global Universal CAR-T Cell Therapy Market Share by Application: 2025 vs 2032
Figure 7. Hematoma
Figure 8. Solid Tumor
Figure 9. Universal CAR-T Cell Therapy Report Years Considered
Figure 10. Global Universal CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Universal CAR-T Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Universal CAR-T Cell Therapy Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Universal CAR-T Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Universal CAR-T Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Universal CAR-T Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Universal CAR-T Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Universal CAR-T Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Universal CAR-T Cell Therapy Market Share by Players in 2025
Figure 19. Global Top Universal CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Universal CAR-T Cell Therapy as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Universal CAR-T Cell Therapy Revenue in 2025
Figure 21. North America Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
Figure 22. North America Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
Figure 23. Europe Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
Figure 24. Europe Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
Figure 27. Latin America Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
Figure 28. Latin America Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Universal CAR-T Cell Therapy Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Universal CAR-T Cell Therapy Market Share by Application (2021-2026)
Figure 31. Cellectis Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 32. Allogene Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 33. Caribou Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 34. Poseida Therapeutics Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 35. Bangyao Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 36. Usano Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 37. Keji Pharmaceutical Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 38. Beiheng Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 39. Grace Biotechnology Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 40. Celyad Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 41. CRISPR Therapeutics Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 42. Precision BioSciences Revenue Growth Rate in Universal CAR-T Cell Therapy Business (2021-2026)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed